Loading
Journal of AIDS and HIV Treatment
ISSN: 2688-7436
Volume 2, Issue 2, p42-74
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
Older Versus Younger Men Who Have Sex with Men: Awareness of and Potential Barriers to the Use of Pre-Exposure Prophylaxis (PrEP) Medication to Prevent the Transmission of HIV
Men who have sex with other men (MSM) comprise the single largest group of individuals contracting HIV in the United States, accounting for more than one-half of all new HIV diagnoses.
J AIDS HIV Treat, 2020, Volume 2, Issue 2, p42-50 | DOI: 10.33696/AIDS.2.006Trend of HIV Infection in a Specialized Medical Unit, 2007- 2016
The human immunodeficiency virus (HIV) has caused one of the pandemics that has most affected the world population [1], and continues to be a serious problem, since to date it has not been possible to eradicate or prevent totally new cases.
J AIDS HIV Treat, 2020, Volume 2, Issue 2, p51-56 | DOI: 10.33696/AIDS.2.007AIDS Related Histoplasmosis, Treatment and Prophylaxis: the Mycology Unit of FJ Muniz Hospital Experience
Classic histoplasmosis is a systemic endemic mycosis due to the dimorphic fungus Histoplasma capsulatum var. capsulatum. This microorganism lives as mold in rich nitrogen soil in temperate and humid regions.
J AIDS HIV Treat, 2020, Volume 2, Issue 2, p57-62 | DOI: 10.33696/AIDS.2.008Anaphylaxis Drug Reaction after Initiation of Bictegravir
A 44-year old Ethiopian female with a history of HIV and latent tuberculosis treated with three months of rifampin presented to the Ruth M Rothstein CORE Center complaining of pruritic rash that started the previous night.
J AIDS HIV Treat, 2020, Volume 2, Issue 2, p63-67 | DOI: 10.33696/AIDS.2.009Early Insights into COVID-19 in Persons Living with HIV and Cardiovascular Manifestations
At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China.
J AIDS HIV Treat, 2020, Volume 2, Issue 2, p68-74 | DOI: 10.33696/AIDS.2.010HIV-1 Treatment Failure among Population Taking Antiretroviral Therapy in Ethiopia
For more than 35 years, the world has grappled with an AIDS epidemic that has claimed an estimated 35.0 million [28.9 million-41.5 million] lives and at its peak threatened global stability and security.
HIV RNA Load and Antiretroviral Drug Resistance of HIV-1 Strains in Chad on Dried Blood Spots: A Pilot Study
In low-income Sub-Saharan Africa countries, peripheral blood HIV RNA levels monitoring twice a year in antiretroviral (ARV) drugs treated patient is a major WHO recommendation since 2013.
Stroke and Visual Loss in a Young Girl with Dengue Fever – Report of a Case and a Mini Review
The case of a young girl with Dengue fever presenting with seizures and bilateral visual loss is presented. At the time of presentation, she had right hemiplegia and dysarthria but was not dysphasic. Fundoscopy revealed presence of macular and disc oedema in the right eye and vitreous haemorrhage in the left eye.
HIV/AIDS Care and Support Services Satisfaction for Orphan and Vulnerable Children in Northwest Ethiopia: Mixed Method Study
Background: The provision of comprehensive care and support services to orphans and disadvantaged children that are individualized and tailored through the use of child- and family-centered information is critical but little if any information is available on satisfaction with HIV/AIDS care among orphans and vulnerable children in Gondar. Therefore, this study aimed to assess the satisfaction of HIV/AIDS care and support service delivered to caregivers of Orphans and Vulnerable Children, Gondar City, 2023.
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.